EQRx is a biotechnology company focused on developing important new medicines and offering them at lower prices through strategic partnerships with stakeholders from across the healthcare system and cutting-edge science and technology.
EQRX
1.71 as of 5/26/23
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/11/2021 | Series B | $570MM raised | $XXX.XX | $XXX.XX |
| 1/13/2020 | Series A | $243.88MM raised | $XXX.XX | $XXX.XX |
